FT Health Discusses Advice On Antibiotics, Features Interview With Chief Executive Of ViiV Healthcare

FT Health: Antibiotics under scrutiny
The latest issue of the Financial Times’ weekly global health newsletter discusses an article published in the BMJ that raises questions about antibiotic resistance and prescribing practices. The newsletter also features an interview with Deborah Waterhouse, chief executive of ViiV Healthcare, who discusses an experimental injectable HIV treatment, and provides a roundup of other global health-related news stories (Jack, 7/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.